Upgrade to SI Premium - Free Trial

Insmed (INSM)

106.64 -1.98 (1.82%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (7/30/26)

Latest Headlines

Form SCHEDULE 13G/A INSMED Inc Filed by: JPMORGAN CHASE & CO July 22, 2026 1:39 PM - SEC Filing Raymond James sees potential for beats across biopharma coverage July 21, 2026 6:12 AM - StreetInsider BMO Capital Starts Insmed (INSM) at Outperform July 20, 2026 4:36 PM - StreetInsider H.C. Wainwright Reiterates Buy Rating on Insmed (INSM) July 20, 2026 6:44 AM - StreetInsider Insmed (INSM) Reiterated at Buy by Stifel After TPIP P2b Trial Data July 17, 2026 7:20 AM - StreetInsider Insmed reports 12-month OLE data for TPIP in PAH patients July 16, 2026 7:02 AM - StreetInsider Form 8-K INSMED Inc For: Jul 16 July 16, 2026 7:01 AM - SEC Filing Insmed Announces Positive 12-Month Data from the Ongoing Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Patients with Pulmonary Arterial Hypertension July 16, 2026 7:00 AM - PR NewsWire Insmed (INSM) PT Raised to $161 at Wells Fargo July 15, 2026 6:52 AM - StreetInsider Form 4 INSMED Inc For: Jul 09 Filed by: Lewis William July 10, 2026 4:03 PM - SEC Filing Form 144 INSMED Inc Filed by: Lewis William July 9, 2026 4:30 PM - SEC Filing Form 4 INSMED Inc For: Jul 06 Filed by: Flammer Martina M.D. July 8, 2026 4:03 PM - SEC Filing Form 144 INSMED Inc Filed by: Flammer Martina M.D. July 6, 2026 4:20 PM - SEC Filing Palvella Therapeutics adds Matt Pauls to its board of directors June 30, 2026 7:30 AM - StreetInsider Form 4 INSMED Inc For: Jun 25 Filed by: Lewis William June 26, 2026 4:04 PM - SEC Filing Form 144 INSMED Inc Filed by: Lewis William June 25, 2026 4:14 PM - SEC Filing Form 4 INSMED Inc For: Jun 23 Filed by: Butera Samuele June 24, 2026 4:16 PM - SEC Filing Form 3 INSMED Inc For: Jun 23 Filed by: Butera Samuele June 24, 2026 4:13 PM - SEC Filing Form 4 INSMED Inc For: Jun 22 Filed by: Smith Michael Alexander June 24, 2026 4:12 PM - SEC Filing Insmed names Samuele Butera to lead global respiratory unit June 23, 2026 7:00 AM - StreetInsider Insmed Appoints Samuele Butera as Senior Vice President, General Manager, Global Respiratory June 23, 2026 7:00 AM - PR NewsWire Form 144 INSMED Inc Filed by: Smith Michael Alexander June 22, 2026 4:21 PM - SEC Filing Insmed (INSM) PT Lowered to $160 at Evercore ISI June 22, 2026 7:43 AM - StreetInsider Recent weakness provides an opportunity to buy this stock June 16, 2026 12:00 PM - StreetInsider Insmed (INSM) PT Lowered to $192 at Mizuho June 16, 2026 6:40 AM - StreetInsider NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance June 11, 2026 8:16 PM - StreetInsider Nasdaq-100 Index® June 2026 Quarterly Changes June 11, 2026 8:00 PM - StreetInsider Form 4 INSMED Inc For: Jun 08 Filed by: Lewis William June 10, 2026 4:06 PM - SEC Filing Insmed (INSM) Reiterated at Overweight by Cantor Fitzgerald June 10, 2026 7:02 AM - StreetInsider Form 144 INSMED Inc Filed by: Lewis William June 8, 2026 4:34 PM - SEC Filing Form 144 INSMED Inc Filed by: Flammer Martina M.D. June 5, 2026 4:19 PM - SEC Filing Form 4 INSMED Inc For: Jun 03 Filed by: Adsett Roger June 5, 2026 4:16 PM - SEC Filing Form 4 INSMED Inc For: Jun 03 Filed by: Bonstein Sara June 5, 2026 4:15 PM - SEC Filing Form 4 INSMED Inc For: Jun 03 Filed by: Smith Michael Alexander June 5, 2026 4:14 PM - SEC Filing Form 4 INSMED Inc For: Jun 03 Filed by: Lewis William June 5, 2026 4:12 PM - SEC Filing Form 4 INSMED Inc For: Jun 03 Filed by: Flammer Martina M.D. June 5, 2026 4:12 PM - SEC Filing Insmed (INSM) PT Lowered to $195 at RBC Capital June 5, 2026 5:42 AM - StreetInsider Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) June 4, 2026 7:00 AM - PR NewsWire Form 144 INSMED Inc Filed by: Bonstein Sara June 3, 2026 4:41 PM - SEC Filing Form 144 INSMED Inc Filed by: Flammer Martina M.D. June 3, 2026 4:36 PM - SEC Filing Form 144 INSMED Inc Filed by: Adsett Roger June 3, 2026 4:29 PM - SEC Filing Form 144 INSMED Inc Filed by: Smith Michael Alexander June 3, 2026 4:22 PM - SEC Filing Form 144 INSMED Inc Filed by: Lewis William June 3, 2026 4:10 PM - SEC Filing JPMorgan says large-cap biotech is back as profits and pipelines fuel upside May 28, 2026 4:07 PM - StreetInsider Insmed to Present at the 2026 Goldman Sachs Annual Global Healthcare Conference May 27, 2026 7:00 AM - PR NewsWire Form 144 INSMED Inc Filed by: Smith Michael Alexander May 22, 2026 4:55 PM - SEC Filing Form 4 INSMED Inc For: May 22 Filed by: Smith Michael Alexander May 22, 2026 4:25 PM - SEC Filing Form 4 INSMED Inc For: May 18 Filed by: Lewis William May 20, 2026 4:07 PM - SEC Filing JPMorgan sees biotech sector at inflection point, resumes coverage on 14 Firms May 20, 2026 3:10 PM - StreetInsider JPMorgan Reinstates Insmed (INSM) at Overweight May 20, 2026 4:30 AM - StreetInsider Form 144 INSMED Inc Filed by: Lewis William May 18, 2026 4:54 PM - SEC Filing Form S-3ASR INSMED Inc May 15, 2026 5:06 PM - SEC Filing Form SCHEDULE 13G/A INSMED Inc Filed by: Darwin Global Management, Ltd. May 15, 2026 5:04 PM - SEC Filing Form 4 INSMED Inc For: May 13 Filed by: Bonstein Sara May 15, 2026 4:13 PM - SEC Filing Form 4 INSMED Inc For: May 13 Filed by: SCHAFER CAROL May 15, 2026 4:13 PM - SEC Filing Form 4 INSMED Inc For: May 13 Filed by: Adsett Roger May 15, 2026 4:13 PM - SEC Filing Form 4 INSMED Inc For: May 13 Filed by: ANDERSON ELIZABETH M May 15, 2026 4:13 PM - SEC Filing Form 4 INSMED Inc For: May 13 Filed by: Smith Michael Alexander May 15, 2026 4:12 PM - SEC Filing Form 4 INSMED Inc For: May 13 Filed by: Flammer Martina M.D. May 15, 2026 4:12 PM - SEC Filing Form 4 INSMED Inc For: May 13 Filed by: SHAROKY MELVIN MD May 15, 2026 4:12 PM - SEC Filing Form 4 INSMED Inc For: May 13 Filed by: Brennan David R May 15, 2026 4:12 PM - SEC Filing Form 4 INSMED Inc For: May 13 Filed by: Desjardins Clarissa May 15, 2026 4:12 PM - SEC Filing Form 4 INSMED Inc For: May 13 Filed by: LEE LEO May 15, 2026 4:12 PM - SEC Filing Form 4 INSMED Inc For: May 13 Filed by: Lewis William May 15, 2026 4:12 PM - SEC Filing Form 8-K INSMED Inc For: May 13 May 15, 2026 4:03 PM - SEC Filing Insmed (INSM) PT Lowered to $162 at Evercore ISI May 15, 2026 6:13 AM - StreetInsider Form 144 INSMED Inc Filed by: Flammer Martina M.D. May 14, 2026 5:20 PM - SEC Filing Form 144 INSMED Inc Filed by: Adsett Roger May 13, 2026 5:25 PM - SEC Filing Form 144 INSMED Inc Filed by: Smith Michael Alexander May 13, 2026 5:19 PM - SEC Filing Form 144 INSMED Inc Filed by: Bonstein Sara May 13, 2026 5:18 PM - SEC Filing Form 144 INSMED Inc Filed by: Flammer Martina M.D. May 13, 2026 5:17 PM - SEC Filing Form 144 INSMED Inc Filed by: Lewis William May 13, 2026 5:14 PM - SEC Filing Form 4 INSMED Inc For: May 11 Filed by: Flammer Martina M.D. May 13, 2026 4:50 PM - SEC Filing Insmed (INSM) PT Lowered to $185 at Truist Securities May 13, 2026 1:06 PM - StreetInsider BofA Securities Reiterates Buy Rating on Insmed (INSM); 'pullback overdone' May 12, 2026 12:02 PM - StreetInsider Form 144 INSMED Inc Filed by: Flammer Martina M.D. May 11, 2026 4:47 PM - SEC Filing Buy the dip in this stock after a 23% earnings drop: Wall Street May 8, 2026 11:00 AM - StreetInsider Insmed (INSM) PT Lowered to $205 at RBC Capital May 8, 2026 7:32 AM - StreetInsider Insmed (INSM) PT Raised to $226 at Guggenheim May 8, 2026 7:22 AM - StreetInsider Insmed (INSM) PT Lowered to $160 at Wells Fargo May 8, 2026 6:57 AM - StreetInsider Insmed (INSM) Tops Q1 EPS by 20c May 7, 2026 7:39 AM - StreetInsider Form 8-K INSMED Inc For: May 07 May 7, 2026 7:02 AM - SEC Filing Form 10-Q INSMED Inc For: Mar 31 May 7, 2026 7:01 AM - SEC Filing Insmed Reports First-Quarter 2026 Financial Results and Provides Business Update May 7, 2026 7:00 AM - PR NewsWire Insmed and Ty Pennington Team Up to Drive Awareness and Proper Diagnosis of Bronchiectasis May 6, 2026 4:30 PM - PR NewsWire Form 4 INSMED Inc For: May 04 Filed by: Lewis William May 6, 2026 4:12 PM - SEC Filing Form SCHEDULE 13G INSMED Inc Filed by: FMR LLC May 6, 2026 11:24 AM - SEC Filing Form 144 INSMED Inc Filed by: Lewis William May 4, 2026 4:55 PM - SEC Filing Insmed to Present Data Across Its Respiratory Portfolio, Including Late-Breaking ARIKAYCE® Results from Phase 3b ENCORE Study, at the American Thoracic Society International Conference 2026 May 4, 2026 7:00 AM - PR NewsWire Form SCHEDULE 13G INSMED Inc Filed by: VANGUARD CAPITAL MANAGEMENT LLC April 30, 2026 10:38 AM - SEC Filing Insmed to Present at May 2026 Investor Conferences April 30, 2026 7:00 AM - PR NewsWire Insmed to Host First-Quarter 2026 Financial Results Conference Call on Thursday, May 7, 2026 April 23, 2026 7:01 AM - PR NewsWire Full Article List